When Does Microbot Medical Report Earnings?
MBOT · Nasdaq · Next earnings date for Microbot Medical Inc., estimated from its SEC filing history, with a live countdown in trading days.
Next earnings date
Monday, November 2, 2026
Fiscal Q3 2026 results · quarter ended September 30, 2026 · ±7 days
Estimated from 1 prior fiscal Q3 report with a less regular pattern — expect the actual date within about a week of this one.
After that
Fiscal Q4 2026
Estimated Mar 15, 2027 · after the close
Fiscal year
January 1 – December 31
fiscal 2026 ends Dec 31, 2026
How this estimate is made
Companies report on a rhythm. We read every Form 8-K earnings release and 10-Q/10-K Microbot Medical has filed with the SEC, work out how many days after each fiscal quarter ended the results came out and on which weekday, and project that pattern onto the current quarter — using the same fiscal quarter from prior years, since fourth-quarter reports run later than the others. The result is snapped to a trading day and capped at the SEC filing deadline for a non accelerated filer.
Whether a company reports before the open or after the close comes from the time its past earnings 8-Ks reached the SEC. When Microbot Medical announces an exact date, this page switches from estimated to confirmed. Until then, verify the date with the company's investor relations site before trading around it.
Frequently asked questions
When does Microbot Medical (MBOT) report earnings?›
Microbot Medical is expected to report Fiscal Q3 2026 earnings on Monday, November 2, 2026, after the market closes.
How many trading days until MBOT earnings?›
21 trading days (30 calendar days) as of Saturday, October 3, 2026, counting weekdays and skipping NYSE/Nasdaq holidays.
Does MBOT report before or after the market opens?›
Microbot Medical typically reports after the market closes, based on when its past earnings 8-K filings reached the SEC.
Estimated dates are projections from public SEC filings, not announcements by Microbot Medical Inc. Confirm with the company before making decisions. Not investment advice.